[Sensibilization rate with haptenes in patients with neoplasms].
D001555:Benzene Derivatives / Q000276:immunology*; D004342:Drug Hypersensitivity / Q000276:immunology*; D006241:Haptens / Q000276:immunology; D006801:Humans; D009369:Neoplasms / Q000276:immunology*
D001555:Benzene Derivatives; D006241:Haptens
Die Sensibilisierungsrate mit Haptenen bei Tumorträgern